Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle
This article was originally published in The Gray Sheet
Executive Summary
Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26
You may also be interested in...
Invitrogen Expands High-Throughput Assays With Molecular Probes Purchase
Invitrogen will enhance its high-throughput, drug discovery screening assays with Molecular Probes, Inc.'s fluorescent molecular labeling detection systems under a $325 mil. proposed acquisition
Invitrogen Expands High-Throughput Assays With Molecular Probes Purchase
Invitrogen will enhance its high-throughput, drug discovery screening assays with Molecular Probes, Inc.'s fluorescent molecular labeling detection systems under a $325 mil. proposed acquisition
Fisher Expanding In-House Manufacturing Capability Through Cole-Parmer
Fisher Scientific International will broaden its offerings of instrumentation and equipment used in life-science research and increase its in-house manufacturing capabilities through acquisition of privately held Cole-Parmer Instrument Company.